Josh McGovern

11PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersFood properties (incl. characteristics and health benefits)Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 09, 2025
Does Modified 5-Item Frailty Index Correlate With Survival in Oropharyngeal Squamous Cell Carcinoma?

Marta Chmielecka, Rhona Hurley, Mohd Afid Mohd Slim

|Aug 21, 2024
The prevalence and prognostic value of systemic inflammation in good performance status patients with advanced, inoperable non-small cell lung cancer receiving palliative radiotherapy: Comparison of composite ratios and cumulative scores.

Josh McGovern, Fraser O'Rourke, Sarah Will

|Mar 27, 2024
The Relationship between Liver Volume, Clinicopathological Characteristics and Survival in Patients Undergoing Resection with Curative Intent for Non-Metastatic Colonic Cancer.

Josh McGovern, Charles Mackay, Rhiannon Freireich

|Dec 13, 2023
The relationship between clinicopathological variables, systemic inflammation, and CT-derived body composition with survival in patients with advanced non-small cell lung cancer receiving nivolumab as a second-line treatment.

Randa Saeed, Josh McGovern, Hugo Bench

|Apr 29, 2023
The relationship between micronutrient status, frailty, systemic inflammation, and clinical outcomes in patients admitted to hospital with COVID-19.

Josh McGovern, John Wadsworth, Anthony Catchpole

|Dec 14, 2022
Lactate dehydrogenase: relationship with the diagnostic GLIM criterion for cachexia in patients with advanced cancer.

Josh McGovern, Ross D Dolan, Claribel P L Simmons

Pageof 2

Frequent Collaborators

5 joint publications

Ross D Dolan

3 joint publications

Donald C McMillan

1 joint publications

Randa Saeed

1 joint publications

Barry J A Laird